Compare Stocks: SIBN, ATRC, TMDX, and INSP

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ATRC AtriCure	$58.97 -0.6%	$54.17	$25.36 ▼ $61.70	$3.02B	1.24	900,345 shs	497,103 shs
INSP Inspire Medical Systems	$71.09 -2.2%	$67.54	$38.91 ▼ $147.03	$2.06B	0.73	867,687 shs	592,143 shs
SIBN SiBone	$21.48 -0.4%	$19.16	$11.48 ▼ $21.89	$956.16M	0.66	597,286 shs	469,088 shs
TMDX TransMedics Group	$70.74 -1.8%	$83.92	$60.10 ▼ $156.00	$2.44B	1.94	809,860 shs	789,689 shs

The 7 Hottest IPO Stories of 2026

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ATRC AtriCure	-0.56%	+5.17%	-1.65%	+68.29%	+58.91%
INSP Inspire Medical Systems	-2.37%	+3.45%	+2.92%	+43.97%	-12.88%
SIBN SiBone	-0.37%	+9.15%	+15.48%	+29.24%	+39.48%
TMDX TransMedics Group	-1.83%	-0.06%	-18.69%	-2.10%	-40.82%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ATRC AtriCure	$58.97 -0.6%	$54.17	$25.36 ▼ $61.70	$3.02B	1.24	900,345 shs	497,103 shs
INSP Inspire Medical Systems	$71.09 -2.2%	$67.54	$38.91 ▼ $147.03	$2.06B	0.73	867,687 shs	592,143 shs
SIBN SiBone	$21.48 -0.4%	$19.16	$11.48 ▼ $21.89	$956.16M	0.66	597,286 shs	469,088 shs
TMDX TransMedics Group	$70.74 -1.8%	$83.92	$60.10 ▼ $156.00	$2.44B	1.94	809,860 shs	789,689 shs

The 7 Hottest IPO Stories of 2026

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ATRC AtriCure	-0.56%	+5.17%	-1.65%	+68.29%	+58.91%
INSP Inspire Medical Systems	-2.37%	+3.45%	+2.92%	+43.97%	-12.88%
SIBN SiBone	-0.37%	+9.15%	+15.48%	+29.24%	+39.48%
TMDX TransMedics Group	-1.83%	-0.06%	-18.69%	-2.10%	-40.82%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
ATRC AtriCure	2.42	Hold	$55.70	-5.55% Downside
INSP Inspire Medical Systems	2.05	Hold	$68.82	-3.19% Downside
SIBN SiBone	2.71	Moderate Buy	$24.50	14.06% Upside
TMDX TransMedics Group	2.33	Hold	$115.60	63.42% Upside

Current Analyst Ratings Breakdown

Latest SIBN, ATRC, TMDX, and INSP Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
10/21/2026	ATRC AtriCure	Citigroup Subscribe to MarketBeat All Access to unlock brokerage rankings	Reiterated Rating	Market Outperform
10/21/2026	ATRC AtriCure	UBS Group Subscribe to MarketBeat All Access to unlock brokerage rankings	Downgrade	Buy ➝ Sell
10/21/2026	ATRC AtriCure	Citizens Jmp Subscribe to MarketBeat All Access to unlock brokerage rankings	Boost Price Target	Market Outperform	$52.00 ➝ $68.00
10/14/2026	INSP Inspire Medical Systems	Truist Financial Subscribe to MarketBeat All Access to unlock brokerage rankings	Boost Price Target	Hold	$62.00 ➝ $78.00
10/14/2026	SIBN SiBone	Truist Financial Subscribe to MarketBeat All Access to unlock brokerage rankings	Boost Price Target	Buy	$23.00 ➝ $25.00
10/13/2026	INSP Inspire Medical Systems	Mizuho Subscribe to MarketBeat All Access to unlock brokerage rankings	Set Price Target		$75.00
10/13/2026	TMDX TransMedics Group	Canaccord Genuity Group Subscribe to MarketBeat All Access to unlock brokerage rankings	Lower Price Target	Buy	$95.00 ➝ $94.00
10/12/2026	ATRC AtriCure	BTIG Research Subscribe to MarketBeat All Access to unlock brokerage rankings	Boost Price Target	Buy	$55.00 ➝ $63.00
10/8/2026	ATRC AtriCure	Weiss Ratings Subscribe to MarketBeat All Access to unlock brokerage rankings	Upgrade	Hold (C-) ➝ Hold (C)
10/7/2026	TMDX TransMedics Group	Barclays Subscribe to MarketBeat All Access to unlock brokerage rankings	Initiated Coverage	Overweight	$120.00
10/6/2026	INSP Inspire Medical Systems	Barclays Subscribe to MarketBeat All Access to unlock brokerage rankings	Initiated Coverage	Underweight	$65.00

(Data available from 10/24/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
ATRC AtriCure	$534.53M	5.61	$0.31 per share	189.46	$9.89 per share	5.96
INSP Inspire Medical Systems	$898.74M	2.29	$2.80 per share	25.37	$26.88 per share	2.64
SIBN SiBone	$213.60M	4.46	N/A	N/A	$4.09 per share	5.25
TMDX TransMedics Group	$668.47M	3.66	$3.86 per share	18.35	$13.79 per share	5.13

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
ATRC AtriCure	-$11.45M	$0.21	280.82	131.04	N/A	1.85%	2.34%	1.77%	11/3/2026 (Confirmed)
INSP Inspire Medical Systems	$145.42M	$4.62	15.39	46.16	5.49	15.03%	8.64%	7.45%	11/2/2026 (Estimated)
SIBN SiBone	-$18.90M	-$0.34	N/A	N/A	N/A	-6.85%	-8.23%	-6.07%	11/2/2026 (Estimated)
TMDX TransMedics Group	$190.29M	$3.89	18.19	31.30	0.99	22.69%	15.88%	5.95%	11/5/2026 (Estimated)

Latest SIBN, ATRC, TMDX, and INSP Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
11/5/2026	Q3 2026	TMDX TransMedics Group	$0.2976	N/A	N/A	N/A	$178.06 million	N/A
11/3/2026	Q3 2026	ATRC AtriCure	-$0.0485	N/A	N/A	N/A	$151.05 million	N/A
11/2/2026	Q3 2026	INSP Inspire Medical Systems	$0.0870	N/A	N/A	N/A	$204.31 million	N/A
11/2/2026	Q3 2026	SIBN SiBone	-$0.13	N/A	N/A	N/A	$55.31 million	N/A
8/4/2026	Q2 2026	TMDX TransMedics Group	$0.4955	$0.44	-$0.0555	$0.41	$184.00 million	$189.95 million
8/3/2026	Q2 2026	INSP Inspire Medical Systems	-$0.2359	$0.14	+$0.3759	$0.01	$194.72 million	$200.58 million
8/3/2026	Q2 2026	SIBN SiBone	-$0.1495	-$0.09	+$0.0595	-$0.09	$55.34 million	$56.01 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
ATRC AtriCure	N/A	N/A	N/A	N/A	N/A
INSP Inspire Medical Systems	N/A	N/A	N/A	N/A	N/A
SIBN SiBone	N/A	N/A	N/A	N/A	N/A
TMDX TransMedics Group	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
ATRC AtriCure	0.14	4.22	3.19
INSP Inspire Medical Systems	N/A	8.55	6.16
SIBN SiBone	0.20	9.15	7.55
TMDX TransMedics Group	1.62	6.62	6.07

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
ATRC AtriCure	99.11%
INSP Inspire Medical Systems	94.91%
SIBN SiBone	98.11%
TMDX TransMedics Group	99.67%

Insider Ownership

Company	Insider Ownership
ATRC AtriCure	4.00%
INSP Inspire Medical Systems	2.20%
SIBN SiBone	4.00%
TMDX TransMedics Group	6.90%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
ATRC AtriCure	1,350	50.87 million	48.83 million	Optionable
INSP Inspire Medical Systems	1,333	28.91 million	28.27 million	Optionable
SIBN SiBone	376	44.35 million	42.58 million	Optionable
TMDX TransMedics Group	898	34.56 million	32.18 million	Optionable

SIBN, ATRC, TMDX, and INSP Headlines

Recent News About These Companies

TransMedics to Report Third Quarter 2026 Financial Results on November 5, 2026

October 22 at 4:05 PM | prnewswire.com

TransMedics Group (NASDAQ:TMDX) & QuidelOrtho (NASDAQ:QDEL) Financial Comparison

October 22 at 2:15 AM | americanbankingnews.com

TransMedics Group Inc TMDX

October 20, 2026 | morningstar.comM

Stifel holds TransMedics Group stock at USD 65.00 amid competition

October 20, 2026 | ad-hoc-news.deA

TransMedics Group - Some Hiccups In The Long Term Growth Story

October 20, 2026 | seekingalpha.com

TransMedics Group, Inc. (TMDX) Stock Analysis: Unlocking a 39% Upside Potential in Healthcare Innovation

October 19, 2026 | directorstalkinterviews.com

Stifel holds TransMedics stock at Hold amid competition concerns

October 18, 2026 | ad-hoc-news.deA

17,734 Shares in TransMedics Group, Inc. $TMDX Purchased by Annex Advisory Services LLC

October 18, 2026 | marketbeat.com

TransMedics Group (TMDX) Stock Looks Undervalued On Current Earnings

October 17, 2026 | finance.yahoo.com

TransMedics Group (NASDAQ:TMDX) Shares Down 5.7% - Here's What Happened

October 16, 2026 | marketbeat.com

iRhythm Technologies (NASDAQ:IRTC) versus TransMedics Group (NASDAQ:TMDX) Head-To-Head Comparison

October 15, 2026 | americanbankingnews.com

Canaccord Genuity Group Issues Pessimistic Forecast for TransMedics Group (NASDAQ:TMDX) Stock Price

October 15, 2026 | americanbankingnews.com

TransMedics Group (NASDAQ:TMDX) Stock Gets Price Target Trim from Canaccord Genuity Group

October 13, 2026 | marketbeat.com

Barclays initiates coverage of TransMedics Group at overweight

October 8, 2026 | msn.com

TransMedics Group consensus price target rises 10.91% to MX$1,984.96

October 8, 2026 | msn.com

41,109 TransMedics Group, Inc. $TMDX Shares Sold by Zevenbergen Capital Investments LLC

October 8, 2026 | marketbeat.com

TransMedics Group stock gets USD 120.00 target from Barclays

October 8, 2026 | ad-hoc-news.deA

TransMedics Group (NASDAQ:TMDX) Shares Climb 4.2% - Time to Buy?

October 7, 2026 | marketbeat.com

TransMedics Group (NASDAQ:TMDX) Now Covered by Analysts at Barclays

October 7, 2026 | marketbeat.com

TransMedics Group, Inc. $TMDX Shares Purchased by Congress Asset Management Co.

October 7, 2026 | marketbeat.com

TransMedics Group, Inc. (NASDAQ:TMDX) Stock Has Average Price Target of $121.10 According to Brokerages

October 5, 2026 | marketbeat.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

SIBN, ATRC, TMDX, and INSP Company Descriptions

AtriCure NASDAQ:ATRC

$58.97 -0.33 (-0.56%)

Closing price 10/23/2026 04:00 PM Eastern

Extended Trading

$58.64 -0.34 (-0.57%)

As of 10/23/2026 07:30 PM Eastern

AtriCure, Inc. develops, manufactures, and sells devices for surgical ablation of cardiac tissue, exclusion of the left atrial appendage, and temporarily blocking pain by ablating peripheral nerves to medical centers in the United States, Europe, the Asia-Pacific, and internationally. The company offers Isolator Synergy Clamps, single-use disposable radio frequency products; multifunctional pens and linear ablation devices, such as the MAX Pen device that enables surgeons to evaluate cardiac arrhythmias, perform temporary cardiac pacing, sensing, and stimulation, and ablate cardiac tissue with the same device; and the Coolrail device, which enables users to make longer linear lines of ablation. It also provides cryoICE Cryoablation System that enables the user to make linear ablations of varied lengths; EPi-Sense Systems, a single-use disposable device used for the treatment of symptomatic, drug-refractory, and long-standing persistent atrial fibrillation; cryoSPHERE probe, which provides temporary pain relief by applying cryothermic energy to targeted intercoastal peripheral nerves in the ribcage; AtriClip System, an implantable device coupled to a single-use disposable applier; and LARIAT System, a suture-based solution for soft-tissue closure. In addition, the company sells Lumitip dissectors to separate tissues to provide access to key anatomical structures that are targeted for ablation; Glidepath guides for placement of clamps; Subtle Cannula's to support access for EPi-Sense catheters; and various reusable cardiac surgery instruments. It markets and sells its products through independent distributors and direct sales personnel. The company was incorporated in 2000 and is headquartered in Mason, Ohio.

Inspire Medical Systems NYSE:INSP

$71.09 -1.57 (-2.16%)

Closing price 10/23/2026 03:59 PM Eastern

Extended Trading

$71.20 +0.11 (+0.16%)

As of 10/23/2026 08:00 PM Eastern

Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.

SiBone NASDAQ:SIBN

$21.48 -0.08 (-0.37%)

Closing price 10/23/2026 04:00 PM Eastern

Extended Trading

$21.47 -0.01 (-0.05%)

As of 10/23/2026 07:30 PM Eastern

SI-BONE, Inc., a medical device company, that operate to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers proprietary minimally invasive surgical implant system to address sacroiliac joint dysfunction and fusion, adult deformity and degeneration, and pelvic trauma; and implantable bone products. The company also provides iFuse-3D, a titanium implant that combines the triangular cross-section of the iFuse implant with the proprietary 3D-printed porous surface and fenestrated design; iFuse-TORQ, a set of 3D-printed threaded implants designed to treat pelvic trauma; and iFuse Bedrock Granite implant provides sacroiliac fusion and sacropelvic fixation as a foundational element for segmental spinal fusion. It markets its products primarily with a direct sales force, as well as through agents and resellers. SI-BONE, Inc. was incorporated in 2008 and is headquartered in Santa Clara, California.

TransMedics Group NASDAQ:TMDX

$70.74 -1.32 (-1.83%)

Closing price 10/23/2026 04:00 PM Eastern

Extended Trading

$69.94 -0.80 (-1.13%)

As of 10/23/2026 07:56 PM Eastern

TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its OCS includes OCS LUNG for the preservation of standard criteria donor lungs for double-lung transplantation; OCS Heart, a technology for preservation of DBD donor hearts deemed unsuitable due to limitations of cold storage and for ex vivo reanimation, functional monitoring, and beating-heart preservation of donation-after-circulatory-death hearts; and OCS Liver for the preservation of DBD and DCD of donor livers. The company also developed national OCS program, a turnkey solution for outsourced organ retrieval; and provides OCS organ management and logistics services, including aviation and ground transportation, and other coordination activity. The company was founded in 1998 and is headquartered in Andover, Massachusetts.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest SIBN, ATRC, TMDX, and INSP Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest SIBN, ATRC, TMDX, and INSP Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

SIBN, ATRC, TMDX, and INSP Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

SIBN, ATRC, TMDX, and INSP Company Descriptions

AtriCure NASDAQ:ATRC

Inspire Medical Systems NYSE:INSP

SiBone NASDAQ:SIBN

TransMedics Group NASDAQ:TMDX

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest SIBN, ATRC, TMDX, and INSP Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest SIBN, ATRC, TMDX, and INSP Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

SIBN, ATRC, TMDX, and INSP Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

SIBN, ATRC, TMDX, and INSP Company Descriptions

AtriCure NASDAQ:ATRC

Inspire Medical Systems NYSE:INSP

SiBone NASDAQ:SIBN

TransMedics Group NASDAQ:TMDX

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools